As of April 15, 2025, Celltrion (068270.KS) has a market cap of $24.36 billion USD. According to our data, Celltrion is ranked No.790 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $24.36 B |
-13.67%
|
Dec 30, 2024 | $28.22 B |
-1.91%
|
Dec 28, 2023 | $28.77 B |
25.88%
|
Dec 29, 2022 | $22.86 B |
-15.50%
|
Dec 30, 2021 | $27.05 B |
-43.53%
|
Dec 30, 2020 | $47.90 B |
102.31%
|
Dec 30, 2019 | $23.68 B |
-14.58%
|
Dec 28, 2018 | $27.72 B |
2.65%
|
Dec 28, 2017 | $27.01 B |
109.98%
|
Dec 29, 2016 | $12.86 B |
33.46%
|
Dec 30, 2015 | $9.64 B |
124.03%
|
Dec 30, 2014 | $4.30 B |
6.37%
|
Dec 30, 2013 | $4.04 B |
-24.33%
|
Dec 28, 2012 | $5.34 B |
24.09%
|
Dec 29, 2011 | $4.31 B |
8.69%
|
Dec 30, 2010 | $3.96 B |
123.87%
|
Dec 30, 2009 | $1.77 B |
51.52%
|
Dec 31, 2008 | $1.17 B |
226.73%
|
Dec 28, 2007 | $0.36 B |
-29.76%
|
Dec 28, 2006 | $0.51 B |
-30.63%
|
Dec 29, 2005 | $0.73 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
Market Cap | = | 068270.KS Stock Price | * | 068270.KS Shares Outstanding |
= | $111.91 | * | 0.22 B | |
= | $24.36 B |